Dragica Micanovic
Belgrade, SE, Serbia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
FFAR2 activation induces IL-22-dependent intestinal immune responses to suppress CNS autoimmunity.
Journal: EMBO molecular medicine
Published: January 20, 2026
Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.
Journal: Diabetes
Published: August 07, 2025
Sepsis prevents the development of experimental type 1 diabetes.
Journal: Frontiers in immunology
Published: July 03, 2025
Multiple low dose streptozotocin-induced diabetes as a model for studying autoimmune diabetes in humans.
Journal: Animal models and experimental medicine
Published: October 25, 2024
Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes.
Journal: International journal of molecular sciences
Published: April 03, 2024
Defining the ferroptotic phenotype of beta cells in type 1 diabetes and its inhibition as a potential antidiabetic strategy.
Journal: Frontiers in endocrinology
Published: May 25, 2023
Ethyl pyruvate ameliorates acute respiratory distress syndrome in mice.
Journal: European journal of pharmacology
Published: May 24, 2023
Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3+ Treg in the Small Intestine.
Journal: Molecules (Basel, Switzerland)
Published: February 09, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026